The objectives include investigating the association between serum magnesium and zinc levels and Lp-PLA2 activity in MetS patients, comparing these levels between MetS patients and healthy controls, and examining the correlation between Lp-PLA2 levels and other cardiovascular risk factors in MetS patients. This evidence concerns the gene PLA2G7 and metabolic syndrome.